| Issue Date | Title | Author(s) |
| 2021-04-26 | An electronic decision support‐based complex intervention to improve management of cardiovascular risk in primary health care: a cluster randomised trial (INTEGRATE) | Webster, R; Usherwood, T; Joshi, R; Saini, B; Armour, C; Critchley, S; Di Tanna, GL; Galgey, S; Hespe, CM; Jan, S; Karia, A; Kaur, B; Krass, I; Laba, T; Li, Q; Lo, S; Peiris, DP; Reid, C; Rodgers, A; Shiel, L; Strathdee, J; Zamora, N; Patel, A |
| 2020-11 | Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial. | Wang, N; Salam, A; Webster, R; de Silva, A; Guggilla, R; Stepien, S; Mysore, J; Billot, L; Jan, S; Maulik, PK; Naik, N; Selak, V; Thom, S; Prabhakaran, D; Patel, A; Rodgers, A; TRIUMPH Study Group |
| 2021-01-01 | Effects of Low-dose Triple Combination Therapy on Time at Target Blood Pressure – Results From the TRIUMPH Randomized Controlled Trial | Gnanenthiran, S; Wang, N; Salam, A; Webster, R; de Silva, A; Schutte, A; Patel, A; Rodgers, A |
| 2019-10-01 | Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial | Lung, T; Jan, S; de Silva, HA; Guggilla, R; Maulik, PK; Naik, N; Patel, A; de Silva, AP; Rajapakse, S; Ranasinghe, G; Prabhakaran, D; Rodgers, A; Salam, A; Selak, V; Stepien, S; Thom, S; Webster, R; Lea-Laba, T |
| 2019-03-01 | Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study | Jun, M; Jardine, MJ; Perkovic, V; Pilard, Q; Billot, L; Rodgers, A; Rogers, K; Gallagher, M |
| 2021-09-18 | Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial. | Chow, CK; Atkins, ER; Hillis, GS; Nelson, MR; Reid, CM; Schlaich, MP; Hay, P; Rogers, K; Billot, L; Burke, M; Chalmers, J; Neal, B; Patel, A; Usherwood, T; Webster, R; Rodgers, A; QUARTET Investigators, |
| 2016-09-23 | An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: Protocol for a cluster randomized controlled trial | Hayek, A; Joshi, R; Usherwood, T; Webster, R; Kaur, B; Saini, B; Armour, C; Krass, I; Laba, TL; Reid, C; Shiel, L; Hespe, C; Hersch, F; Jan, S; Lo, S; Peiris, D; Rodgers, A; Patel, A |
| 2019-01-01 | Reaching cardiovascular prevention guideline targets with a polypill-based approach: A meta-Analysis of randomised clinical trials | Selak, V; Webster, R; Stepien, S; Bullen, C; Patel, A; Thom, S; Arroll, B; Bots, ML; Brown, A; Crengle, S; Dorairaj, P; Elley, CR; Grobbee, DE; Harwood, M; Hillis, GS; Laba, TL; Neal, B; Peiris, D; Rafter, N; Reid, C; Stanton, A; Tonkin, A; Usherwood, T; Wadham, A; Rodgers, A |
| 2020-03 | The 2016 Joint European Prevention Guidelines and the uses of polypills: Time to update the evidence. | Webster, R; Grobbee, D; Rodgers, A |
| 2020-10-02 | Ultra-low-dose quadruple combination blood pressure lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol. | Chow, CK; Atkins, ER; Billot, L; Chalmers, J; Hillis, GS; Hay, P; Neal, B; Nelson, M; Patel, A; Reid, CM; Schlaich, M; Usherwood, T; Webster, R; Rodgers, A |
